Dassault Systèmes (Euronext Paris: FR0014003TT8, DSY.PA) today announced its investment in Click Therapeutics, a leader in prescription digital therapeutics and software-enhanced drug therapies. The transaction advances Dassault Systèmes’ transformation of the patient experience in life sciences and healthcare through end-to end technology solutions used across the healthcare ecosystem.
The transaction strengthens the existing relationship between Dassault Systèmes’ MEDIDATA brand and Click Therapeutics, helping to improve patient engagement – post-trial through commercialization – and advancing the Patient Experience to deliver end-to-end technology solutions across the healthcare ecosystem.